ALPHA COGNITION INC (ACOG) Fundamental Analysis & Valuation

NASDAQ:ACOG • CA02074J5017

Current stock price

6.75 USD
+0.26 (+4.01%)
Last:

This ACOG fundamental analysis includes valuation metrics, fair value assessment, financial health analysis, profitability trends, growth metrics and dividend sustainability analysis.

1

1. ACOG Profitability Analysis

1.1 Basic Checks

  • ACOG had negative earnings in the past year.
  • In the past year ACOG has reported a negative cash flow from operations.
  • ACOG had negative earnings in each of the past 5 years.
  • ACOG had a negative operating cash flow in each of the past 5 years.
ACOG Yearly Net Income VS EBIT VS OCF VS FCFACOG Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2020 2021 2022 2023 2024 -5M -10M -15M

1.2 Ratios

  • Looking at the Return On Assets, with a value of -42.06%, ACOG is in line with its industry, outperforming 54.46% of the companies in the same industry.
  • The Return On Equity of ACOG (-57.42%) is comparable to the rest of the industry.
Industry RankSector Rank
ROA -42.06%
ROE -57.42%
ROIC N/A
ROA(3y)-333.55%
ROA(5y)-244.19%
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
ACOG Yearly ROA, ROE, ROICACOG Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2020 2021 2022 2023 2024 0 -10K -20K -30K

1.3 Margins

  • ACOG does not have Profit Margin and Operating Margin and Gross Margin available, so we won't be analyzing them here.
Industry RankSector Rank
OM N/A
PM (TTM) N/A
GM N/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
ACOG Yearly Profit, Operating, Gross MarginsACOG Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2020 2021 2022 2023 2024

More info and screens

ROAROEROICOperating and Profit MarginShow most profitable peers

8

2. ACOG Health Analysis

2.1 Basic Checks

  • ACOG has no outstanding debt. Therefor its Debt/Equity and Debt/FCF ratios are 0 and belong to the best of the industry.
ACOG Yearly Shares OutstandingACOG Yearly Shares OutstandingYearly Shares Outstanding 2020 2021 2022 2023 2024 10M 20M 30M 40M
ACOG Yearly Total Debt VS Total AssetsACOG Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2020 2021 2022 2023 2024 10M 20M 30M 40M 50M

2.2 Solvency

  • An Altman-Z score of 4.33 indicates that ACOG is not in any danger for bankruptcy at the moment.
  • With a decent Altman-Z score value of 4.33, ACOG is doing good in the industry, outperforming 72.09% of the companies in the same industry.
  • ACOG has no outstanding debt. Therefor its Debt/Equity and Debt/FCF ratios are 0 and belong to the best of the industry.
Industry RankSector Rank
Debt/Equity 0
Debt/FCF N/A
Altman-Z 4.33
ROIC/WACCN/A
WACCN/A
ACOG Yearly LT Debt VS Equity VS FCFACOG Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2020 2021 2022 2023 2024 0 10M 20M 30M 40M

2.3 Liquidity

  • A Current Ratio of 6.69 indicates that ACOG has no problem at all paying its short term obligations.
  • With a decent Current ratio value of 6.69, ACOG is doing good in the industry, outperforming 65.89% of the companies in the same industry.
  • A Quick Ratio of 6.03 indicates that ACOG has no problem at all paying its short term obligations.
  • The Quick ratio of ACOG (6.03) is better than 62.79% of its industry peers.
Industry RankSector Rank
Current Ratio 6.69
Quick Ratio 6.03
ACOG Yearly Current Assets VS Current LiabilitesACOG Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2020 2021 2022 2023 2024 10M 20M 30M 40M 50M

More info and screens

WACCDebt/EquityHow to determine the health of a companyAltman-Z scoreShow peers with great health

3

3. ACOG Growth Analysis

3.1 Past

EPS 1Y (TTM)N/A
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%39.22%
Revenue 1Y (TTM)N/A
Revenue growth 3YN/A
Revenue growth 5YN/A
Sales Q2Q%N/A

3.2 Future

  • The Earnings Per Share is expected to grow by 35.44% on average over the next years. This is a very strong growth
  • The Revenue is expected to grow by 93.00% on average over the next years. This is a very strong growth
EPS Next Y-18.13%
EPS Next 2Y35.44%
EPS Next 3YN/A
EPS Next 5YN/A
Revenue Next Year128.58%
Revenue Next 2Y135%
Revenue Next 3Y134.79%
Revenue Next 5Y93%

3.3 Evolution

ACOG Yearly Revenue VS EstimatesACOG Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2025 2026 2027 2028 2029 2030 50M 100M 150M 200M 250M
ACOG Yearly EPS VS EstimatesACOG Yearly EPS VS EstimatesYearly EPS VS Estimates 2021 2022 2024 2025 2026 2027 -2 -4 -6 -8 -10

More info and screens

Find the best growth stocksShow best growing peers

1

4. ACOG Valuation Analysis

4.1 Price/Earnings Ratio

  • The Price/Earnings Ratio is negative for ACOG. In the last year negative earnings were reported.
  • Besides the negative Price/Earnings Ratio, also the Forward Price/Earnings Ratio is negative for ACOG. No positive earnings are expected for the next year.
Industry RankSector Rank
PE N/A
Fwd PE N/A
ACOG Price Earnings VS Forward Price EarningsACOG Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 20 40 60 80 100

4.2 Price Multiples

Industry RankSector Rank
P/FCF N/A
EV/EBITDA N/A
ACOG Per share dataACOG EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 0.5 -0.5 1 -1 1.5

4.3 Compensation for Growth

  • ACOG's earnings are expected to grow with 35.44% in the coming years. This may justify a more expensive valuation.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y35.44%
EPS Next 3YN/A

More info and screens

Price/EarningsPrice/FCFFCF per shareEV/EBITDAPEG RATIOShow best valued peers

0

5. ACOG Dividend Analysis

5.1 Amount

  • ACOG does not give a dividend.
Industry RankSector Rank
Dividend Yield 0%

More info and screens

Find the best dividend stocksShow peers with best dividend

ACOG Fundamentals: All Metrics, Ratios and Statistics

ALPHA COGNITION INC

NASDAQ:ACOG (4/15/2026, 8:00:00 PM)

6.75

+0.26 (+4.01%)

Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupPharmaceuticals, Biotechnology & Life Sciences
GICS IndustryBiotechnology
Earnings (Last)03-26
Earnings (Next)N/A
Inst Owners52.7%
Inst Owner Change-0.11%
Ins Owners11.38%
Ins Owner Change40.94%
Market Cap146.95M
Revenue(TTM)N/A
Net Income(TTM)-19.47M
Analysts82.86
Price Target18.36 (172%)
Short Float %1.7%
Short Ratio4.52
Dividend
Industry RankSector Rank
Dividend Yield 0%
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)1
Avg EPS beat(2)28.4%
Min EPS beat(2)-24.95%
Max EPS beat(2)81.76%
EPS beat(4)2
Avg EPS beat(4)32.67%
Min EPS beat(4)-24.95%
Max EPS beat(4)81.76%
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)1
Avg Revenue beat(2)11.14%
Min Revenue beat(2)-14.76%
Max Revenue beat(2)37.04%
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)0%
PT rev (3m)0%
EPS NQ rev (1m)0%
EPS NQ rev (3m)0%
EPS NY rev (1m)0%
EPS NY rev (3m)0%
Revenue NQ rev (1m)0%
Revenue NQ rev (3m)0%
Revenue NY rev (1m)0%
Revenue NY rev (3m)0%
Valuation
Industry RankSector Rank
PE N/A
Fwd PE N/A
P/S 19.78
P/FCF N/A
P/OCF N/A
P/B 4.33
P/tB 4.38
EV/EBITDA N/A
EPS(TTM)-1.17
EYN/A
EPS(NY)-1.38
Fwd EYN/A
FCF(TTM)-0.73
FCFYN/A
OCF(TTM)-0.72
OCFYN/A
SpS0.34
BVpS1.56
TBVpS1.54
PEG (NY)N/A
PEG (5Y)N/A
Graham Number0 (-100%)
Profitability
Industry RankSector Rank
ROA -42.06%
ROE -57.42%
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM N/A
PM (TTM) N/A
GM N/A
FCFM N/A
ROA(3y)-333.55%
ROA(5y)-244.19%
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexgc growth 3YN/A
ROICexgc growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
F-Score6
Asset Turnover0.16
Health
Industry RankSector Rank
Debt/Equity 0
Debt/FCF N/A
Debt/EBITDA N/A
Cap/Depr N/A
Cap/Sales N/A
Interest Coverage N/A
Cash Conversion N/A
Profit Quality N/A
Current Ratio 6.69
Quick Ratio 6.03
Altman-Z 4.33
F-Score6
WACCN/A
ROIC/WACCN/A
Cap/Depr(3y)12.76%
Cap/Depr(5y)24.09%
Cap/Sales(3y)N/A
Cap/Sales(5y)N/A
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)N/A
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%39.22%
EPS Next Y-18.13%
EPS Next 2Y35.44%
EPS Next 3YN/A
EPS Next 5YN/A
Revenue 1Y (TTM)N/A
Revenue growth 3YN/A
Revenue growth 5YN/A
Sales Q2Q%N/A
Revenue Next Year128.58%
Revenue Next 2Y135%
Revenue Next 3Y134.79%
Revenue Next 5Y93%
EBIT growth 1Y-49.29%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next Year124.69%
EBIT Next 3YN/A
EBIT Next 5YN/A
FCF growth 1Y-72.83%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y-70.96%
OCF growth 3YN/A
OCF growth 5YN/A

ALPHA COGNITION INC / ACOG Fundamental Analysis FAQ

Can you provide the ChartMill fundamental rating for ALPHA COGNITION INC?

ChartMill assigns a fundamental rating of 3 / 10 to ACOG.


What is the valuation status of ALPHA COGNITION INC (ACOG) stock?

ChartMill assigns a valuation rating of 1 / 10 to ALPHA COGNITION INC (ACOG). This can be considered as Overvalued.


What is the profitability of ACOG stock?

ALPHA COGNITION INC (ACOG) has a profitability rating of 1 / 10.


What is the expected EPS growth for ALPHA COGNITION INC (ACOG) stock?

The Earnings per Share (EPS) of ALPHA COGNITION INC (ACOG) is expected to decline by -18.13% in the next year.